
Stenride MP 2mg/500mg/15mg Tablet SR
Marketer
Alvoncare Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Stenride MP 2mg/500mg/15mg Tablet SR
Combiflex DM 2mg/500mg/15mg Extended-Release Tablets effectively manage blood glucose in adults with type 2 diabetes. This medication, used alongside diet and exercise, enhances insulin efficacy, thus reducing blood sugar. Dosage and frequency should strictly adhere to your physician's instructions. Administer with food to prevent gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, omit the missed dose and resume the regular schedule. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or skipped meals elevates hypoglycemia risk; diligent blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Kidney function tests will be evaluated before treatment initiation. Limit alcohol consumption to minimize potential side effects.
Uses of Stenride MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Stenride MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Stenride MP 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Stenride MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Stenride MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Stenride MP 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Stenride MP 2mg/500mg/15mg Tablet SR works:
Stenride MP 2mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their combined action improves blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Stenride MP 2mg/500mg/15mg SR tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Stenride MP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination tablet, Stenride MP 2mg/500mg/15mg, is likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired if your blood glucose levels are abnormally low or elevated. Refrain from driving should these conditions arise.
KidneyCAUTION
Exercise caution when administering Stenride MP 2mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Stenride MP 2mg/500mg/15mg SR tablets. Physician consultation is advised. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Stenride MP 2mg/500mg/15mg SR tablets. Dosage modification may be necessary; physician consultation is advised. Stenride MP 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Stenride MP 2mg/500mg/15mg Tablet SR :
Should you forget to take a Stenride MP 2mg/500mg/15mg Tablet SR, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Stenride MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
